BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12733714)

  • 1. A family of autosomal dominant hypocalcemia with an activating mutation of calcium-sensing receptor gene.
    Chikatsu N; Watanabe S; Takeuchi Y; Muraosa Y; Sasaki S; Oka Y; Fukumoto S; Fujita T
    Endocr J; 2003 Feb; 50(1):91-6. PubMed ID: 12733714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study.
    Obermannova B; Sumnik Z; Dusatkova P; Cinek O; Grant M; Lebl J; Hendy GN
    Eur J Endocrinol; 2016 Apr; 174(4):K1-K11. PubMed ID: 26764418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).
    Dong B; Endo I; Ohnishi Y; Kondo T; Hasegawa T; Amizuka N; Kiyonari H; Shioi G; Abe M; Fukumoto S; Matsumoto T
    J Bone Miner Res; 2015 Nov; 30(11):1980-93. PubMed ID: 25967373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia.
    Okazaki R; Chikatsu N; Nakatsu M; Takeuchi Y; Ajima M; Miki J; Fujita T; Arai M; Totsuka Y; Tanaka K; Fukumoto S
    J Clin Endocrinol Metab; 1999 Jan; 84(1):363-6. PubMed ID: 9920108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CASR gene activating mutations in two families with autosomal dominant hypocalcemia.
    Guarnieri V; Valentina D'Elia A; Baorda F; Pazienza V; Benegiamo G; Stanziale P; Copetti M; Battista C; Grimaldi F; Damante G; Pellegrini F; D'Agruma L; Zelante L; Carella M; Scillitani A
    Mol Genet Metab; 2012 Nov; 107(3):548-52. PubMed ID: 22789683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.
    Kinoshita Y; Hori M; Taguchi M; Watanabe S; Fukumoto S
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E363-8. PubMed ID: 24297799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel activating mutation of human calcium-sensing receptor in a family with autosomal dominant hypocalcaemia.
    Baran N; ter Braak M; Saffrich R; Woelfle J; Schmitz U
    Mol Cell Endocrinol; 2015 May; 407():18-25. PubMed ID: 25766501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia in a family with two uncommon parathyroid hormone polymorphisms.
    Alvarez-Hernández D; Santamaría I; Rodríguez-García M; Iglesias P; Delgado-Lillo R; Cannata-Andía JB
    J Mol Endocrinol; 2003 Oct; 31(2):255-62. PubMed ID: 14519094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914.
    Park SY; Mun HC; Eom YS; Baek HL; Jung TS; Kim CH; Hong S; Lee S
    Clin Endocrinol (Oxf); 2013 May; 78(5):687-93. PubMed ID: 23009664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium: identification of a novel gain of function mutation (Ser(820)Phe) in the calcium-sensing receptor.
    Nagase T; Murakami T; Tsukada T; Kitamura R; Chikatsu N; Takeo H; Takata N; Yasuda H; Fukumoto S; Tanaka Y; Nagata N; Yamaguchi K; Akatsu T; Yamamoto M
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2681-7. PubMed ID: 12050233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal dominant hypocalcemia due to a truncation in the C-tail of the calcium-sensing receptor.
    Maruca K; Brambilla I; Mingione A; Bassi L; Capelli S; Brasacchio C; Soldati L; Cisternino M; Mora S
    Mol Cell Endocrinol; 2017 Jan; 439():187-193. PubMed ID: 27561204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia.
    Hirai H; Nakajima S; Miyauchi A; Nishimura K; Shimizu N; Shima M; Michigami T; Ozono K; Okada S
    J Hum Genet; 2001; 46(1):41-4. PubMed ID: 11289719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Calcium-Sensing Receptor (CASR) Mutation in a Family with Autosomal Dominant Hypocalcemia Type 1 (ADH1): Genetic Study over Three Generations and Clinical Characteristics.
    Zung A; Barash G; Banne E; Levine MA
    Horm Res Paediatr; 2023; 96(5):473-482. PubMed ID: 36812896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation (E767K) in the second extracellular loop of the calcium sensing receptor in a family with autosomal dominant hypocalcemia.
    Uçkun-Kitapçi A; Underwood LE; Zhang J; Moats-Staats B
    Am J Med Genet A; 2005 Jan; 132A(2):125-9. PubMed ID: 15551332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired growth and intracranial calcifications in autosomal dominant hypocalcemia caused by a GNA11 mutation.
    Tenhola S; Voutilainen R; Reyes M; Toiviainen-Salo S; Jüppner H; Mäkitie O
    Eur J Endocrinol; 2016 Sep; 175(3):211-8. PubMed ID: 27334330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation of the primary protein kinase C phosphorylation site in the calcium-sensing receptor causes autosomal dominant hypocalcemia.
    Lazarus S; Pretorius CJ; Khafagi F; Campion KL; Brennan SC; Conigrave AD; Brown EM; Ward DT
    Eur J Endocrinol; 2011 Mar; 164(3):429-35. PubMed ID: 21135065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant hypocalcemia caused by an activating mutation of the calcium-sensing receptor gene: the first case report in Korea.
    Kim MY; Tan AH; Ki CS; Lee JI; Jang HW; Shin HW; Kim SW; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    J Korean Med Sci; 2010 Feb; 25(2):317-20. PubMed ID: 20119591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of p.Arg205Cys in CASR in an autosomal dominant hypocalcaemia type 1 pedigree: A case report.
    Ji Y; Kang C; Chen J; Zhang L
    Medicine (Baltimore); 2021 Jun; 100(25):e26443. PubMed ID: 34160437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia.
    Letz S; Haag C; Schulze E; Frank-Raue K; Raue F; Hofner B; Mayr B; Schöfl C
    PLoS One; 2014; 9(12):e115178. PubMed ID: 25506941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey.
    Raue F; Pichl J; Dörr HG; Schnabel D; Heidemann P; Hammersen G; Jaursch-Hancke C; Santen R; Schöfl C; Wabitsch M; Haag C; Schulze E; Frank-Raue K
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):760-5. PubMed ID: 21645025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.